Robert Knapp
Neurology · Canandaigua, NYNPI 1043239445
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,016 and has fallen 94.1% since, to $60 in 2024.
Across 116 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$245
- Sunovion Pharmaceuticals Inc.$215
- Sanofi$159
- Lundbeck LLC$121
- Novartis$115
- Acorda Therapeutics, Inc$93
- plus $865 from 23 others
What the payments were for
- Speaking & faculty fees$935%
- Food & beverage$1,66092%
- Education$603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 21 | $245 |
| Sunovion Pharmaceuticals Inc. | 16 | $215 |
| Sanofi | 8 | $159 |
| Lundbeck LLC | 7 | $121 |
| Novartis | 8 | $115 |
| Acorda Therapeutics, Inc | 5 | $93 |
| Amgen | 5 | $91 |
| Genentech USA, Inc. | 4 | $73 |
| Biogen | 5 | $72 |
| Lilly USA, LLC | 4 | $64 |
| Astellas Pharma US Inc | 1 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| MDD US Operations, LLC | 4 | $59 |
| EMD Serono, Inc. | 3 | $54 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Livanova USA, Inc. | 2 | $32 |
| UCB, Inc. | 2 | $31 |
| Amneal Pharmaceuticals LLC | 2 | $31 |
| Neurocrine Biosciences, Inc. | 2 | $29 |
| Mallinckrodt Enterprises LLC | 1 | $29 |
| Grifols USA, LLC | 2 | $28 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Greenwich Biosciences, Inc. | 1 | $18 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| CSL Behring | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,813 in reported general payments places this provider in the 55th percentile of 1,623 neurology providers in New York.
Other neurology in Canandaigua
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.